TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9094885

Group type: EXPERIMENTAL
Intervention: Lifestyle modification (diet, alcohol, smoking, and weight loss)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Increased intakes of monounsaturated fat relative to saturated fat and stearic acid (18:0) consumption
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Modifications reducing body mass index by 5 kg/m2, quitting a 10 cigarette/d smoking habit, and reducing dietary cholesterol intake by 100 mg/d
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Dietary and lifestyle modification
Number of subjects: 94
Study: 8244194

Group type: EXPERIMENTAL
Intervention: Metronidazole-nystatin vagitories
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo vagitories
Number of subjects: 66
Study: 3857148

Group type: EXPERIMENTAL
Intervention: Fluor‐Protector
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: Duraphat
Number of subjects: 787

Group type: COMPARATOR
Intervention: Control
Number of subjects: 787
Study: 30819379

Group type: EXPERIMENTAL
Intervention: Spironolactone therapy
Number of subjects: 1767

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 1767
Study: 30566701

Group type: EXPERIMENTAL
Intervention: DAVS (Digitally Assisted Vitreoretinal System)
Number of subjects: 40

Group type: COMPARATOR
Intervention: AM (Analog Microscope)
Number of subjects: 40
Study: 27688160

Group type: EXPERIMENTAL
Intervention: Disrupted stimulation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Walking mode
Number of subjects: 12

Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 12
Study: 24882909

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestion to 'sleep deeper'
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control tape
Number of subjects: 70
Study: 22897460

Group type: EXPERIMENTAL
Intervention: Aliskiren/amlodipine 150/5mg for 1 week, then up-titration to 300/10 mg for 7 weeks
Number of subjects: 485

Group type: COMPARATOR
Intervention: Amlodipine 5 mg for 1 week, then up-titration to 10 mg for 7 weeks
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Aliskiren/amlodipine combination therapy
Number of subjects: 485

Group type: COMPARATOR
Intervention: Amlodipine monotherapy
Number of subjects: 485
Study: 21029826

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 18574751

Group type: EXPERIMENTAL
Intervention: 20 mug inhaled procaterol
Number of subjects: 19

Group type: COMPARATOR
Intervention: No-treatment
Number of subjects: 19
Study: 15909359

Group type: EXPERIMENTAL
Intervention: School lunch + home economics intervention (SL + HE)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: School lunch intervention (SL)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 228
Study: 11839447

Group type: EXPERIMENTAL
Intervention: 50 mg gum
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 100 mg gum
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 200 mg gum
Number of subjects: 84

Group type: COMPARATOR
Intervention: 50 mg capsule
Number of subjects: 84

Group type: COMPARATOR
Intervention: 100 mg capsule
Number of subjects: 84

Group type: COMPARATOR
Intervention: 200 mg capsule
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 50 mg gum (normalized to total drug released)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 100 mg gum (normalized to total drug released)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 200 mg gum (normalized to total drug released)
Number of subjects: 84
Study: 10506315

Group type: EXPERIMENTAL
Intervention: Atracurium 150 microg/kg
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Atracurium 200 microg/kg
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Atracurium 250 microg/kg
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Atracurium 300 microg/kg
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Atracurium 450 microg/kg
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Atracurium 600 microg/kg
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Atracurium (all doses)
Number of subjects: 89
Study: 7672088

Group type: EXPERIMENTAL
Intervention: Immediate treatment with chlorambucil (CLB)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Deferred therapy until progression
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 148
Study: 2178298

Group type: EXPERIMENTAL
Intervention: AVP antagonist [d(CH2)5 Tyr(Me)AVP] 5 micrograms/kg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: AVP antagonist [d(CH2)5 Tyr(Me)AVP] 10 micrograms/kg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl) during insulin-induced hypoglycemia
Number of subjects: 6
Study: 31810437

Group type: COMPARATOR
Intervention: Cannabidiol (CBD) - 100 mg/mL formulation, dose range 50 mg to 600 mg per day, titrated over 2 weeks followed by a 2-week assessment period.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28449630

Group type: EXPERIMENTAL
Intervention: Sevoflurane at 1.0 MAC
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sevoflurane at 1.2 MAC
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sevoflurane at 1.4 MAC
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, assumed to be rocuronium at 0.45 mg/kg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 90
Study: 26084697

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (2 g daily for 6 days)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Breathing a mixture of 60% O2/balance N2
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Breathing air (∼222 kPa N2/59 kPa O2)
Number of subjects: 14
Study: 23578427

Group type: EXPERIMENTAL
Intervention: Autograft (44 patients, using autogeneic hamstring tendons)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Allograft (42 patients, using allogenic lower extremity tendons)
Number of subjects: 86
Study: 21330651

Group type: EXPERIMENTAL
Intervention: Augmented communication interventions with a speech-generating device
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Spoken intervention
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Overall child outcomes
Number of subjects: 53
Study: 19743984

Group type: EXPERIMENTAL
Intervention: Fibre-enriched drinking yogurt
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Regular drinking yogurt
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fresh banana
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plain crackers
Number of subjects: 30

Group type: COMPARATOR
Intervention: Water
Number of subjects: 30
Study: 17347187

Group type: EXPERIMENTAL
Intervention: Tonsillectomy (n=36)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (waiting list, n=34)
Number of subjects: 70
Study: 16137015

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 68
Study: 11246300

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 257
Study: 9519350

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 7846463

Group type: EXPERIMENTAL
Intervention: 5 mg melatonin administered at 1200 hours
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 5 mg melatonin administered at 1700 hours
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 5 mg melatonin administered at 1900 hours
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 5 mg melatonin administered at 2100 hours
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo administered at 1200, 1700, 1900, and 2100 hours
Number of subjects: 18
Study: 3133216

Group type: EXPERIMENTAL
Intervention: Cytostatic bladder instillation (mitomycin C and adriamycin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of long-term and short-term instillation protocols
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adriamycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mitomycin C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short-term prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-term prophylaxis
Number of subjects: 0
Study: 31527670

Group type: EXPERIMENTAL
Intervention: Open-label placebos
Number of subjects: 58

Group type: COMPARATOR
Intervention: No pills (control group)
Number of subjects: 58
Study: 27866000

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: QMix
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 6.5% grape seed extract
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy with optical fiber
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy without optical fiber
Number of subjects: 90

Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Final decontamination protocols (all groups)
Number of subjects: 90
Study: 24687249

Group type: EXPERIMENTAL
Intervention: Filtek™ Silorane
Number of subjects: 72

Group type: COMPARATOR
Intervention: Ceram•X™
Number of subjects: 72
Study: 24152748

Group type: EXPERIMENTAL
Intervention: Multi-micronutrient supplements
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 22120092

Group type: EXPERIMENTAL
Intervention: Tolvaptan 15 mg/day for 7 days
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 18719791

Group type: EXPERIMENTAL
Intervention: Supervised physical activity (1-hour sessions, 3 times a week for 6 months)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control Group (oriented to non-pharmacological treatment)
Number of subjects: 45
Study: 16794490

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 12
Study: 14501741

Group type: EXPERIMENTAL
Intervention: 10 mg vardenafil
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: 20 mg vardenafil
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study: 10750263

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) treatment
Number of subjects: 0
Study: 9108975

Group type: EXPERIMENTAL
Intervention: 1-Day Acuvue lens
Number of subjects: 48

Group type: COMPARATOR
Intervention: Medalist lens
Number of subjects: 48

Group type: COMPARATOR
Intervention: Regular Acuvue lens
Number of subjects: 48
Study: 8267478

Group type: EXPERIMENTAL
Intervention: Hemofiltration
Number of subjects: 18
Study: 2931063

Group type: EXPERIMENTAL
Intervention: sulindac (200 mg twice daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 29218791

Group type: EXPERIMENTAL
Intervention: Gaze-contingent video games for low-cost in-home training of attention and eye movement, over a duration of 8 weeks.
Number of subjects: 8
Study: 28052576

Group type: EXPERIMENTAL
Intervention: 250 mL/day ONS (10.1 KJ and 0.096 g protein per mL) and dietary advice
Number of subjects: 101

Group type: COMPARATOR
Intervention: Dietary advice alone
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: 250 mL/day ONS and dietary advice
Number of subjects: 101
Study: 26168834

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDFT) with LiDCO rapid system
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (routine fluid therapy)
Number of subjects: 52
Study: 23329469

Group type: EXPERIMENTAL
Intervention: SMS-based epilepsy education programme (Mobile Epilepsy Educational System - MEES)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Printed epilepsy educational module
Number of subjects: 144
Study: 21266159

Group type: EXPERIMENTAL
Intervention: Automation-assisted reading of cervical cytology slides paired with manual reading
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual reading of cervical cytology slides
Number of subjects: 0
Study: 20633415

Group type: EXPERIMENTAL
Intervention: intermittent theta burst stimulation (iTBS)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: continuous theta burst stimulation (cTBS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: sham TBS
Number of subjects: 11
Study: 16571907

Group type: EXPERIMENTAL
Intervention: Participants with Williams syndrome (WS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Participants with Down syndrome (DS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Participants with undifferentiated developmental delays
Number of subjects: 28

Group type: COMPARATOR
Intervention: Participants from the general population
Number of subjects: 28
Study: 15650471

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress-reduction program (8 weeks, 2 hours per week)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18
Study: 11369828

Group type: EXPERIMENTAL
Intervention: Trandolapril alone or in combination with verapamil
Number of subjects: 22

Group type: COMPARATOR
Intervention: Beta-blocker (atenolol)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-dihydropyridine calcium channel blocker (verapamil)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Fixed combination of verapamil+trandolapril at half the dose
Number of subjects: 22
Study: 9161390

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 180

Group type: COMPARATOR
Intervention: Nonprotocol use of antibiotics
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Imipenem-cilastatin sodium for 4 weeks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Sterile severe acute pancreatitis
Number of subjects: 180

Group type: COMPARATOR
Intervention: Infected patients
Number of subjects: 180

Group type: COMPARATOR
Intervention: Infection within the first 4 weeks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Infection after 4 weeks
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Imipenem-cilastatin protocol for infections after 4 weeks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Overall mortality rates
Number of subjects: 180
Study: 8233987

Group type: EXPERIMENTAL
Intervention: Touch condition (children patted on the upper arm or shoulder during examination)
Number of subjects: 38

Group type: COMPARATOR
Intervention: No-touch control condition (children received only verbal reassurance without contact)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Touch condition
Number of subjects: 38

Group type: COMPARATOR
Intervention: No-touch control condition
Number of subjects: 38
Study: 3304371

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (1.5‐15 mg/hr)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 30161166

Group type: EXPERIMENTAL
Intervention: Alcohol use
Number of subjects: 5680

Group type: EXPERIMENTAL
Intervention: Tobacco use
Number of subjects: 5680

Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 5680
Study: 27555168

Group type: EXPERIMENTAL
Intervention: Rocuronium (0.9 mg/kg) administered in the MR group (35 patients)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Rocuronium (MR group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (C group; 35 patients)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 70
Study: 25496296

Group type: EXPERIMENTAL
Intervention: Housing First treatment model
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Qualitative component (in-depth interviews)
Number of subjects: 231
Study: 22098540

Group type: EXPERIMENTAL
Intervention: Music intervention with nursing presence
Number of subjects: 34

Group type: COMPARATOR
Intervention: Recorded music
Number of subjects: 34
Study: 20105410

Group type: EXPERIMENTAL
Intervention: Brief physician advice intervention consisting of two 15-minute counseling visits and two follow-up phone calls using motivational interviewing, contracting, diary cards, and take-home exercises
Number of subjects: 996

Group type: COMPARATOR
Intervention: Control group receiving standard care
Number of subjects: 996

Group type: EXPERIMENTAL
Intervention: Brief physician advice intervention
Number of subjects: 996

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 996
Study: 17651376

Group type: EXPERIMENTAL
Intervention: PHA-stimulated CBMC
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: beta-lactoglobulin-stimulated CBMC
Number of subjects: 98

Group type: COMPARATOR
Intervention: Maternal probiotic supplementation
Number of subjects: 98
Study: 15918929

Group type: EXPERIMENTAL
Intervention: Total alcohol consumption
Number of subjects: 2691

Group type: EXPERIMENTAL
Intervention: Wine consumption
Number of subjects: 2691

Group type: EXPERIMENTAL
Intervention: Spirits consumption
Number of subjects: 2691

Group type: COMPARATOR
Intervention: Beer consumption
Number of subjects: 2691
Study: 14569762

Group type: EXPERIMENTAL
Intervention: Reamed nailing
Number of subjects: 102

Group type: COMPARATOR
Intervention: Unreamed nailing
Number of subjects: 102
Study: 9645907

Group type: EXPERIMENTAL
Intervention: Vascular hemostasis device (VasoSeal)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual compression
Number of subjects: 0
Study: 8160607

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with chest pain present at onset (n = 3000)
Number of subjects: 3337

Group type: COMPARATOR
Intervention: Intravenous thrombolysis without chest pain present at onset (n = 337)
Number of subjects: 3337
Study: 3371394

Group type: EXPERIMENTAL
Intervention: Controlled-release metoprolol (CR), 200 mg/day
Number of subjects: 115

Group type: COMPARATOR
Intervention: Conventional metoprolol tablets, 100 mg twice daily
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Controlled-release metoprolol (CR), 100 mg/day
Number of subjects: 115

Group type: COMPARATOR
Intervention: Conventional metoprolol tablets, 50 mg twice daily
Number of subjects: 115
Study: 30477869

Group type: EXPERIMENTAL
Intervention: Verum Acupuncture Group 1 (VA1, 3 times weekly for 4 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Verum Acupuncture Group 2 (VA2, twice weekly for 4 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham Acupuncture Group (SA, twice weekly for 4 weeks)
Number of subjects: 30
Study: 26384960

Group type: EXPERIMENTAL
Intervention: Institutional rearing
Number of subjects: 69

Group type: COMPARATOR
Intervention: Foster care (as part of the Bucharest Early Intervention Project)
Number of subjects: 69
Study: 24135427

Group type: EXPERIMENTAL
Intervention: Oral propranolol, 2 mg/kg/day
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Topical propranolol 1% ointment twice daily
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intralesional propranolol, 1 mg in 1 ml injection once weekly
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 45
Study: 20737274

Group type: EXPERIMENTAL
Intervention: Endoscopic third ventriculostomy (ETV)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Ventriculoperitoneal shunt (VPS)
Number of subjects: 53
Study: 19699864

Group type: EXPERIMENTAL
Intervention: Routine stent-based percutaneous coronary intervention (PCI)
Number of subjects: 2201

Group type: COMPARATOR
Intervention: Optimal medical therapy alone
Number of subjects: 2201
Study: 16551713

Group type: COMPARATOR
Intervention: Physically active, normal weight women (energy expenditure >=1000 kcal/week; BMI 18.5-24.9)
Number of subjects: 27158

Group type: EXPERIMENTAL
Intervention: Inactive, normal weight women
Number of subjects: 27158

Group type: EXPERIMENTAL
Intervention: Active, overweight women
Number of subjects: 27158

Group type: EXPERIMENTAL
Intervention: Inactive, overweight women
Number of subjects: 27158

Group type: EXPERIMENTAL
Intervention: Active, obese women
Number of subjects: 27158

Group type: EXPERIMENTAL
Intervention: Inactive, obese women
Number of subjects: 27158

Group type: COMPARATOR
Intervention: Physically active, normal weight women
Number of subjects: 27158
Study: 15194376

Group type: EXPERIMENTAL
Intervention: D+/R- group
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: D-/R- group
Number of subjects: 297

Group type: COMPARATOR
Intervention: D+/R+, D-/R+, D-/R- groups collectively
Number of subjects: 297
Study: 11518628

Group type: EXPERIMENTAL
Intervention: Topiramate medium dosage (200 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topiramate low dosage (100 mg daily)
Number of subjects: 20
Study: 9424901

Group type: EXPERIMENTAL
Intervention: Anti H. pylori therapy
Number of subjects: 0
Study: 7950197

Group type: EXPERIMENTAL
Intervention: Tong‐Mai oral liquid (Traditional Chinese Medicine)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Mixture ATP (General therapy)
Number of subjects: 65
Study: 3388122

Group type: EXPERIMENTAL
Intervention: Chemonucleolysis
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Microdiscectomy
Number of subjects: 100
Study: 31719073

Group type: EXPERIMENTAL
Intervention: SPIN-SSLED Programme (13 modules delivered live via videoconference over 3 months)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SPIN-SSLED Programme
Number of subjects: 12
Study: 28545400

Group type: EXPERIMENTAL
Intervention: Behavioural medicine intervention in physiotherapy (goal-setting, self-monitoring, feedback) for 4 months
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160
Study: 25116085

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham-hypoxic placebo
Number of subjects: 34
Study: 23389824

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 200 U
Number of subjects: 691

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 300 U
Number of subjects: 691

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 200 U and 300 U
Number of subjects: 691

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 691
Study: 21615936

Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Physical Activity and Cognitive Training (PACT)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Health Education Control
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Physical Activity Training
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Other Participants
Number of subjects: 73